| 善得定治疗急性出血坏死性胰腺炎的前瞻性研究 |
| |
| 引用本文： | 徐青 李厚祥. 善得定治疗急性出血坏死性胰腺炎的前瞻性研究[J]. 南通医学院学报, 1997, 17(3): 323-324 |
| |
| 作者姓名： | 徐青 李厚祥 |
| |
| 作者单位： | Department of General Surgery，Affiliated Hospital of Nantong Medical College，Nantong 226001 |
| |
| 摘 要： | 本文旨在研究早期使用善得定治疗急性出血坏死性胰腺炎对合并症Ｂｉｎｄｅｒ评分的影响。通过前瞻性研究发现，善得定治疗组４３例中，中转手术率为２０．９％，平均住院日２０．５天，无死亡病例发生，善得定治疗组明显优于早期手术组及其他方案保守治疗组，且善得定治疗７２ｈ后患者血清ＣＲＰ及ＬＤＨ明显下降，认为善得是急性出血坏死性胰腺炎保守的良药，腚早期使用。
|
| 关 键 词： | 急性 出血坏死性 胰腺炎 善得定 |
STUDY ON SANDOSTATIN IN THE TREATMENT OF ACUTE HEMORRHAGIC NECROTIZING PANCREATITIS |
| |
| Xu Qing,Li Houxiang,Chen Yuquan. STUDY ON SANDOSTATIN IN THE TREATMENT OF ACUTE HEMORRHAGIC NECROTIZING PANCREATITIS[J]. ACTA Academiae Medicinae Nantong, 1997, 17(3): 323-324 |
| |
| Authors: | Xu Qing Li Houxiang Chen Yuquan |
| |
| Abstract: | This study was designed to observe sandostatin in the treatment of acute hemorrhagic necrotizing pancreatitis. 43 cases were treated by using sandostatin. Among them, only 9 cases(20.9%) had to be treated by operation. No patient died. CRP and LDH decreased rapidly in 72 hours after using sandostatin. The general condition of those cases improved. The results indicate that sandostatin is an effective drug for acute hemorrhagic necrotizing pancreatitis. |
| |
| Keywords: | acute hemorrhagic necrotizing pancreatitis sandostatin |
| 本文献已被 CNKI 维普 等数据库收录！ |
